Companion Diagnostic Market Report: Trends, Forecast, and Competitive Analysis

Publisher: Lucintel
Publication Date: May, 2020
Healthcare / Medical Devices
Pages: 150+
Delivery Format: PDF

Trends, opportunities, and forecast in companion diagnostic market to 2024 by product & service (assays & reagents and software & services), technology (polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH) , next-generation sequencing, and other technologies), indication (oncology, neurology, and other indications), end use (pharmaceutical and biopharmaceutical companies, reference lab, and other end user), and region (North America, Europe, Asia-Pacific, and Rest of the World).

Report Features
Table of Contents
Pricing
Methodology
Request Sample
Compare Offers
Make an Offer

The future of the companion diagnostic market looks promising with opportunities in the pharmaceutical and biopharmaceutical companies, and reference lab. The global companion diagnostic market is ex

pected to grow with a CAGR of 20% from 2019 to 2024. The major growth drivers for this market are improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence , and increasing collaborations and partnerships for companion diagnostics test development.

A report of more than 150 pages developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of companion diagnostic market report download the report brochure

Companion Diagnostic Market by Segment Type

Companion Diagnostic Market Share Analysis of Major Manufacturers

The study includes the companion diagnostic market size and forecast for the global companion diagnostic market through 2024, segmented by product and service, technology, indication, end use, and region as follows:

By Product and Service [$M shipment analysis for 2013 – 2024]:

Assays & Reagents
Software & Services

By Technology [$M shipment analysis for 2013 – 2024]:

Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next-generation Sequencing
Other Technologies

By Indication [$M shipment analysis for 2013 – 2024]:

Oncology
Neurology
Other Indications

By End Use [$M shipment analysis for 2013 – 2024]:

Pharmaceutical and Biopharmaceutical Companies
Reference Lab
Other End Users

By Region [$M shipment analysis for 2013 – 2024]:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
Asia Pacific
- China
- India
- Japan
Rest of the World
- Brazil

Some of the companion diagnostics companies profiled in this report include F. Hoffmann-La Roche, Agilent Technologies, Qiagen, Thermo Fisher Scientific, Abbott Laboratories, Biomérieux, Danaher, Illumina, Myriad Genetics, Arup Laboratories, Sysmex, Hologic, Novartis, Almac Group, and Abnova.

Some of the features of this report:

Market size estimates: Global companion diagnostic market size estimation in terms of value ($M) shipment.
Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
Segmentation analysis: Global market size by various applications such as by product and service, technology, indication, end use, and region.
Regional analysis: Global companion diagnostic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
Growth opportunities: Analysis on growth opportunities in different applications and regions for companion diagnostics in the global companion diagnostic market.
Strategic analysis: This includes M&A, new product development, and competitive landscape for, companion diagnostics in the global companion diagnostic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising potential, high-growth opportunities for the global companion diagnostic market by product and service (assays and reagents and software and services), technology (polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH) , next-generation sequencing, and other technologies), indication (oncology, neurology, others, and other indications), end use (pharmaceutical and biopharmaceutical companies, reference lab, and other end user), and region (North America, Europe, Asia-Pacific, and ROW)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the companion diagnostic market?
Q.5. What are the business risks and threats to the companion diagnostic market?
Q.6. What are emerging trends in this companion diagnostic market and the reasons behind them?
Q.7. What are some changing demands of customers in the companion diagnostic market?
Q.8. What are the new developments in the companion diagnostic market? Which companies are leading these developments?
Q.9. Who are the major players in this companion diagnostic market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this companion diagnostics area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in companion diagnostic market?

Offer Amount (Per user license)	Retail price (Per user license)
$ .00	$4,850

Companion Diagnostic Market Report: Trends, Forecast, and Competitive Analysis

The future of the companion diagnostic market looks promising with opportunities in the pharmaceutical and biopharmaceutical companies, and reference lab. The global companion diagnostic market is ex

Are you looking for a Consultant?

Customers Who Viewed This Item Also Viewed